Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Algios Therapeutics
Algios Therapeutics
Aligos culls another hepatitis B asset, citing inconclusive efficacy data
Fierce Biotech
Fri, 08/4/23 - 10:12 am
Algios Therapeutics
hepatitis B
siRNA
Aligos Therapeutics, developing several different hep B and NASH treatments, files for $100M IPO raise
Endpoints
Mon, 09/28/20 - 10:46 am
IPOs
Algios Therapeutics
NASH
chronic hepatits B